Richard Stone, Md
Clinical trials sponsored by Richard Stone, Md, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug combo targets tough leukemia cases Results expected Dec 2026 (estimated)
- New cocktail targets tough leukemia mutations Results expected Mar 2027 (estimated)